Repaglinide induced Acute Hepatotoxicity
Repaglinide is considered a safe drug; adverse events are mild to moderate which includes
hypoglycemia, headache, nausea, vomiting, diarrhea and dyspepsia as similar to sulphonylureas.
This case report describes a rare side effect of repaglinide. In rare cases, elevated liver enzymes have
been noted. We report a case of acute hepatotoxicity in a 78 year old woman who developed acute
hepatotoxicity while taking repaglinide.
Key Words: hepatotoxicity, hypoglycemia, repaglinide,
JNMA allow to read, download, copy, distribute, print, search, or link to the full texts of its articles and allow readers to use them for any other lawful purpose. The author(s) are allowed to retain publishing rights without restrictions. The JNMA work is licensed under a Creative Commons Attribution 4.0 International License. More about Copyright Policy.